Development of a Transnasal Delivery System for Recombinant Human Growth Hormone (rhGH): Effects of the Concentration and Molecular Weight of Poly-L-arginine on the Nasal Absorption of rhGH in Rats-Reference-Cited by-同舟云学术

Development of a Transnasal Delivery System for Recombinant Human Growth Hormone (rhGH): Effects of the Concentration and Molecular Weight of Poly-L-arginine on the Nasal Absorption of rhGH in Rats

Published:2016 Issue:3 Volume:39 Page:329-335
ISSN:0918-6158
Container-title:Biological & Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Kawashima Ryo¹,Uchida Masaki¹,Yamaki Tsutomu¹,Ohtake Kazuo¹,Hatanaka Tomomi¹²,Uchida Hiroyuki¹,Ueda Hideo¹,Kobayashi Jun¹,Morimoto Yasunori¹³,Natsume Hideshi¹³

Affiliation:

1. Faculty of Pharmaceutical Sciences, Josai University

2. Tokai University School of Medicine

3. Research Institute of TTS Technology, Josai University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/39/3/39_b15-00657/_pdf

Reference24 articles.

1. 1) Parmentier J, Hofhaus G, Thomas S, Cuesta LC, Gropp F, Schröder R, Hartmann K, Fricker G. Improved oral bioavailability of human growth hormone by a combination of liposomes containing bio-enhancers and tetraether–lipids and omeprazole. J. Pharm. Sci., 103, 3985–3993 (2014).